drugset / Trial / NCT04133987
Clinical Trial of the Safety and Immunogenicity of a Tetravalent Dengue Virus Vaccine Admixture TV005 in the Elderly Aged 50-70 Years in Taiwan
Phase 2
Completed
252 enrolled
National Taiwan University Hospital
Centers for Disease Control, Taiwan · collab
RandomizedParallel-groupSingle-blindPrevention
Summary
Phase II, randomized, double-blind, placebo-controlled study of the safety and immunogenicity of the recombinant live attenuated tetravalent dengue virus vaccine admixture TV005 in the elderly in Taiwan
Timeline
- Start
- 2018-10-15
- Primary completion
- 2020-04-30
- Completion
- 2022-09-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TV005 | Vaccine | — | Subcutaneous |